About the School Robert Wood Johnson Medical School Department of Psychiatry -
-

Department of Psychiatry

Research

Research is a vital part of the Department of Psychiatry. We are committed to increase our knowledge through research and apply it directly to the care of the individual patient.

Following is a list of our current research projects area. Please click to see the ongoing research in any given area:

Affective Disorders

Ethnicity & the Diagnosis of Affective Illness
Principal Investigator: Michael Gara, Ph.D.

<<Back to top

Child & Adolescent Psychiatry

Developing Treatment, Treatment Validation, and Treatment Scope in the Setting of an Autism Clinical Trial
Principal Investigator: Sherry Novotny, M.D.

Omega 3 Fatty Acids in the Treatment of Children with Autism Spectrum Disorders
Principal Investigator: Sherry Novotny, M.D.

Oxcarbazine versus Placebo in Childhood Autism
Sherry Novotny, M.D.

Child and Adolescent Psychiatry Trials Network
Principal Investigator: Ted Petti, M.D.

<<Back to top

Depression

Antidepressant Adherence Among Hispanics
Principal Investigator: Alex Interian, Ph.D.

Treating Depression in Parkinson’s Disease: A New Method
Principal Investigator: Roseanne Dobkin, Ph.D.

Treatment of Depression in Parkinson's Disease
Principal Investigator: Matthew Menza, M.D.

Parallel Group Study to Evaluate the Safety & Efficacy of ONO-2333Ms in Patients with Recurrent Major Depressive Disorder
Principal Investigator: Matthew Menza, M.D.

<<Back to top

Fibromyalgia

Eszopiclone in the Treatment of Insomnia and Associated Symptoms of Fibromyalgia
Principal Investigator: Lesley Allen, Ph.D.

Flexible Dose Duloxetine versus Placebo in the Treatment of Fibromyalgia
Principal Investigator: Lesley Allen, Ph.D.

<<Back to top

Generalized Anxiety Disorder

Study Evaluating the Efficacy and Safety of PD0332334 For the Treatment of Generalized Anxiety Disorder
Principal Investigator: Matthew Menza, M.D.

Placebo & Escitalopram Controlled Trial of the Safety and Efficacy of Pexacerfont BMS-560286 in the Treatment of Outpatients with Generalized Anxiety Disorder
Principal Investigator: Matthew Menza, M.D.

<<Back to top

Hispanic / Latino Mental Health

Ethnicity & the Diagnosis of Affective Illness
Principal Investigator: Michael Gara, Ph.D.

Antidepressant Adherence Among Hispanics
Principal Investigator: Alex Interian, Ph.D.

Critical Research Issues in Latino Mental Health
Principal Investigator: Javier Escobar, M.D.

<<Back to top

Insomnia

Eszopiclone in the Treatment of Insomnia and Associated Symptoms of Fibromyalgia
Principal Investigator: Lesley Allen, Ph.D.

Treatment of Insomnia in Patients with Parkinson’s Disease: A Multi-Site, Placebo Controlled Study of Eszopiclone
Principal Investigator: Matthew Menza, M.D.

<<Back to top

Medically Unexplained Physical Symptoms

Medically Unexplained Physical Symptoms in Primary Care Research Center
Principal Investigator: Javier Escobar, M.D.

Managing Unexplained Physical Symptoms:  Bridging Primary and Psychiatric Care
Principal Investigator: Lesley Allen, Ph.D.

<<Back to top

Mental Health in Primary Care

Managing Unexplained Physical Symptoms:  Bridging Primary and Psychiatric Care
Principal Investigator: Lesley Allen, Ph.D.

<<Back to top

Parkinsons Disease

Treating Depression in Parkinson’s Disease: A New Method
Principal Investigator: Roseanne Dobkin, Ph.D.

Treatment of Depression in Parkinson's Disease
Principal Investigator: Matthew Menza, M.D.
Funding Source : National Institute of Neurological disorders and Stroke (NINDS)

Treatment of Insomnia in Patients with Parkinson’s Disease: A Multi-Site, Placebo Controlled Study of Eszopiclone
Principal Investigator: Matthew Menza, M.D.

<<Back to top

Post Traumatic Stress Disorder (PTSD)

Cognitive Behavioral Treatment of PTSD in SMI Clients
Principal Investigator (site): Steven Silverstein, Ph.D.

<<Back to top

Schizophrenia / Serious Mental Illness

Cognitive Behavioral Treatment of PTSD in SMI Clients
Principal Investigator (site): Steven Silverstein, Ph.D.

Effectiveness Trial of Attention Shaping for Schizophrenia
Principal Investigator: Steven Silverstein, Ph.D.

Comparative Study of the MATRICS and IntegNeuro Cognitive Assessment Batteries
Principal Investigator: Steven Silverstein, Ph.D.

Efficacy of Pregnenolone in Patients with Schizophrenia
Principal Investigator (site): Steven Silverstein, Ph.D.

Task Persistence in Smokers With and Without Schizophrenia
Principal Investigator: Marc L. Steinberg, Ph.D.

A Comparison of Motivational Interviewing and Psychoeducation for Smokers with Serious Mental Illness
Principal Investigator: Marc L. Steinberg, Ph.D.

Nicotine Intake in Smokers with Schizophrenia
Principal Investigator: Jill M. Williams, M.D.

Using Peer Counselors to Address Tobacco Among Mental Health Consumers
Principal Investigator: Jill M. Williams, M.D.

<<Back to top

Substance Use Disorders

Maintaining Independence & Sobriety Through Systems Integration, Outreach & Networking: The MISSION Program
Principal Investigator: Anna Kline , Ph.D.

Mental Health and Substance Use Post OIF/OEF
Principal Investigator: Anna Kline , Ph.D.

Drug Abuse Prevention During Developmental Transitions
Principal Investigator: Rutgers , The State University of New Jersey ; Paul Lehrer, Ph.D., Co-investigator

Alcohol Memory & Affective Regulation
Co-Principal Investigators: Paul Lehrer, Ph.D., Marsha Bates, Ph.D. ( Rutgers )

Cue-Elicit Craving and Genetics in Relapse in Cocaine Dependence
Principal Investigator: David Smelson, Psy.D.

Addressing Tobacco in Addictions Treatment Programs
Principal Investigator: Marc L. Steinberg, Ph.D.

<<Back to top

Tobacco Use & Dependence

Task Persistence in Smokers With and Without Schizophrenia
Principal Investigator: Marc L. Steinberg, Ph.D.

A Comparison of Motivational Interviewing and Psychoeducation for Smokers with Serious Mental Illness
Principal Investigator: Marc L. Steinberg, Ph.D.

Nicotine Intake in Smokers with Schizophrenia
Principal Investigator: Jill M. Williams, M.D.

Using Peer Counselors to Address Tobacco Among Mental Health Consumers
Principal Investigator: Jill M. Williams, M.D.

Addressing Tobacco in Addictions Treatment Programs
Principal Investigator: Marc L. Steinberg, Ph.D.

Trial of Selegiline Transdermal System as an Aid For Smoking Cessation
Principal Investigator: Jill M. Williams, M.D.

<<Back to top

 
 
 
 
 

 

-

© 2004 ROBERT WOOD JOHNSON MEDICAL SCHOOL, ALL RIGHTS RESERVED, 675 HOES LANE, PISCATAWAY, NJ 08854

Robert Wood Johnson Medical School Home